|Bid||0.00 x 1400|
|Ask||0.00 x 1100|
|Day's range||223.28 - 227.25|
|52-week range||189.40 - 262.38|
|Beta (5Y monthly)||0.45|
|PE ratio (TTM)||40.91|
|Earnings date||26 Apr 2023 - 01 May 2023|
|Forward dividend & yield||1.76 (0.77%)|
|Ex-dividend date||08 Feb 2023|
|1y target est||257.57|
ResMed ( NYSE:RMD ) Second Quarter 2023 Results Key Financial Results Revenue: US$1.03b (up 16% from 2Q 2022). Net...
ESLOY vs. RMD: Which Stock Is the Better Value Option?
ResMed's (RMD) mask sales growth was strong across the globe, reflecting a post-COVID pandemic awareness about the importance and need for respiratory hygiene and respiratory health.